These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3609314)

  • 1. Molecular mechanism underlying impaired platelet responsiveness in liver cirrhosis.
    Laffi G; Cominelli F; Ruggiero M; Fedi S; Chiarugi V; Gentilini P
    FEBS Lett; 1987 Aug; 220(1):217-9. PubMed ID: 3609314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists.
    Laffi G; Cominelli F; Ruggiero M; Fedi S; Chiarugi VP; La Villa G; Pinzani M; Gentilini P
    Hepatology; 1988; 8(6):1620-6. PubMed ID: 3142812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.
    Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A
    Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet protease, kistomin, selectively cleaves human platelet glycoprotein Ib.
    Huang TF; Chang MC; Teng CM
    Biochim Biophys Acta; 1993 Nov; 1158(3):293-9. PubMed ID: 8251530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis.
    Laffi G; Cominelli F; La Villa G; Fedi S; Pinzani M; Meacci E; Gentilini P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():366-9. PubMed ID: 2959079
    [No Abstract]   [Full Text] [Related]  

  • 6. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom.
    Teng CM; Chen YH; Ouyang C
    Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process.
    Sato T; Nakao K; Hashizume T; Fujii T
    Biochim Biophys Acta; 1987 Nov; 931(2):157-64. PubMed ID: 3663714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
    Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
    Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective aggregation in cirrhosis is independent of in vivo platelet activation.
    Laffi G; Cinotti S; Filimberti E; Ciabattoni G; Caporale R; Marra F; Melani L; Grossi A; Carloni V; Gentilini P
    J Hepatol; 1996 Apr; 24(4):436-43. PubMed ID: 8738730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation.
    Mounier C; Faili A; Vargaftig BB; Bon C; Hatmi M
    Eur J Biochem; 1993 Aug; 216(1):169-75. PubMed ID: 8365403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
    Packham MA; Livne AA; Ruben DH; Rand ML
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production.
    Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
    Arch Int Pharmacodyn Ther; 1990; 307():142-61. PubMed ID: 1982777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist.
    Huang TF; Liu CZ; Yang SH
    Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):1021-7. PubMed ID: 7639679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired platelet aggregation and thromboxane generation in essential fatty acid-deficient rats.
    Takahashi R; Manku MS; Horrobin DF
    J Nutr; 1987 Sep; 117(9):1520-6. PubMed ID: 2888839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of preactivated human blood platelets to restore defective thromboxane synthesis despite prolonged incubation in plasma.
    Stockschläder M; Scharf RE
    Thromb Haemost; 1989 Nov; 62(3):1016-22. PubMed ID: 2512674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levobupivacaine differentially suppresses platelet aggregation by modulating calcium release in a dose-dependent manner.
    Liou JT; Mao CC; Liu FC; Lin HT; Hung LM; Liao CH; Day YJ
    Acta Anaesthesiol Taiwan; 2012 Sep; 50(3):112-21. PubMed ID: 23026170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
    Joseph S; Krishnamurthi S; Kakkar VV
    Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.